Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA, Clinical Trial Updates: GTx, XenoPort and GlaxoSmithKline, Rockwell Medical
Seeking Alpha
Tuesday, April 28, 2009 - 6:11am
tags:
FDA, drug trials, GTx, GSK, Rockwell Medical, XenoPort
Glaxo, Roche Meet Swine-Flu Drug Needs; Vaccine Is Months Away
Bloomberg
Tuesday, April 28, 2009 - 6:10am
tags:
vaccines, Flu, swine flu, GSK, Roche
Gilead, Roche and others will likely see boost in flu treatment sales as outbreak spreads
Yahoo/AP
Monday, April 27, 2009 - 7:46pm
tags:
Gilead Sciences, Flu, Roche, swine flu
Wyeth and Ligand bone drug gets Europe approval
Yahoo/AP
Monday, April 27, 2009 - 7:43pm
tags:
Wyeth, Ligand, Europe, osteoporosis, CONBRIZA
Allergan Moves Up on Low Volume
Yahoo/Zacks.com
Monday, April 27, 2009 - 4:02pm
tags:
Allergan
Earnings Preview: Bristol Myers Squibb
Seeking Alpha
Monday, April 27, 2009 - 3:36pm
tags:
earnings, Bristol-Myers Squibb
Earnings Preview: Pfizer
Seeking Alpha
Monday, April 27, 2009 - 3:35pm
tags:
Pfizer, earnings
Dynavax Surge Not Warranted
Yahoo/AP
Monday, April 27, 2009 - 3:22pm
tags:
Dynavax, Heplivsav
Nexavar Fails in Phase III Skin Cancer Trial
TheStreet.com
Monday, April 27, 2009 - 11:59am
tags:
Nexavar, drug trials, skin cancer, ONYX Pharmaceuticals
Glenmark unit gets first nod for Zetia generic
Economic Times, India
Monday, April 27, 2009 - 11:56am
tags:
Zetia, Glenmark, generics, India, FDA, cholesterol
Sepracor Reports Preliminary Phase III Study Results for OMNARIS HFA Nasal Aerosol in Seasonal Allergic Rhinitis
Yahoo
Monday, April 27, 2009 - 11:54am
tags:
Sepracor, allergic rhinitis.Omnaris, drug trials
Alexion - How Long a 1-Drug Wonder?
Yahoo/Zacks.com
Monday, April 27, 2009 - 11:47am
tags:
Alexion, Soliris
Allos Therapeutics: Smallcap Biotech with FDA Catalyst
Seeking Alpha
Monday, April 27, 2009 - 11:46am
tags:
Allos, cancer, FDA, biotech
Novartis Drug Heralds Era of New Multiple Sclerosis Therapies
Bloomberg
Monday, April 27, 2009 - 11:45am
tags:
Novartis, MS, multiple sclerosis
Merck selects UTSA, Health Science Center to develop vaccine
Bizjournals.com
Monday, April 27, 2009 - 11:35am
tags:
Merck, UTSA, vaccines
Glaxo, Roche Start to Map Swine-Flu Game Plans
WSJ Online
Monday, April 27, 2009 - 11:32am
tags:
GSK, Roche, swine flu, Flu, Tamiflu, RELENZA
Pfizer, Bristol-Myers to report earnings Tuesday
Marketwatch
Monday, April 27, 2009 - 10:49am
tags:
Pfizer, Bristol-Myers Squibb, earnings
XenoPort, Glaxo pain drug fails in midstage study
Yahoo/AP
Monday, April 27, 2009 - 10:47am
tags:
XenoPort, GSK, painkillers, drug trials
Dendreon's Provenge: Moment of Truth
TheStreet.com
Monday, April 27, 2009 - 10:45am
tags:
Dendreon, Provenge, prostate cancer
Merck: It's Not All Crystal Clear
Forbes
Monday, April 27, 2009 - 10:40am
tags:
Merck KGaA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.